Thank you for your submission to EMBO reports. We have now received the three enclosed on it. As you will see, although all the referees find the topic of interest and in principle suitable for us, they also have a umber of concerns that must be addressed before publication in EMBO reports can be considered.
2) In Fig.3C , they suggest that Mps1 may regulate Sgo1 localization not only through the Bub1-Sgo1 pathway. But I think the evidence is too weak. Expression of Mis12-Bub1 (tethering to kinetochores) in Reversine or Hesperadine treated cells will clarify this point.
3) In Fig.4 , they only show that CB-INCENP rescued the alignment defect in Reversine treated cells. It would be much better if they could show that CB-INCENP also rescues the lagging chromosome and missegregation phenotype observed in Reversine treated cells. Fig.4 , their interpretation is that CB-INCENP largely suppresses the defects caused by Mps1-inhibition. They attribute the residual defects to the Mps1-dependent Borealin phosphorylation pathway. This should be shown experimentally. Namely, if Borealin-4TD (phosphomimetic Borealin) is expressed further, the suppression becomes indeed perfect or not. If not, the authors should conclude that Mps1 regulates chromosome alignment (error correction) not only through Aurora B, but also through an unknown pathway. This point is under debate in this field so that more robust experiments are required to conclude the Fig4C model.
4) In

Referee #2:
In this study the authors have used a combination of pharmacological inhibitors and immunofluorescence to determine the effects of Mps1 and Aurora B kinase activities on the recruitment of Aurora B and Sgo1 to the inner centromere. The authors conclude that both Mps1 and Aurora B activities are required for Aurora B to be recruited to the inner centromere in a timely manner as cells enter mitosis, and that Mps1 exerts its effect at least in part through the recruitment of Sgo1. In the absence of this the authors show that cells display defects in the error correction of microtubule attachment to kinetochores. The authors results concur with those from the Pellman group implicating Mps1 in the recruitment of Sgo1 to centromeres in budding yeast, but differ in that they postulate mutual dependence of Mps1 and Aurora B.
I have one main concern with this paper as it stands: the authors rely on one inhibitor to inhibit each kinase and do not shown any kinase assays for us to judge how efficient these are in their cells. I recommend that the authors repeat their experiments using another inhibitor for Mps1 and for Aurora B (for example the Astra Zeneca compounds). Better still they might consider repeating their experiments in the analogue-sensitive Mps1 cell-line generated by Prasad Jallepalli. I also suspect that live-cell analyses may be more informative given that the authors postulate that there is a limited time window in which Mps1 and Aurora B act on each other, but this is too much to ask here.
One minor point is that the legend to Fig 2A-C does not mention the numbers of cells and number of independent experiments. Referee #3:
EMBOR-2012-35915V1
In the manuscript entitled "Mps1 promotes rapid centromere accumulation of Aurora B", Maike et al. provide evidence that the mitotic kinase Mps1 contributes to one of the two major pathways important for the proper centromeric localization of Aurora B kinase in early mitosis. The authors demonstrate that centromeric localization of AurB and INCENP is reduced when Mps1 is inhibited using the small molecule compound reversine or siRNA-mediated knockdown of Mps1. The authors further present data indicating that Mps1 might control AurB localization by promoting Bub1 recruitment to the kinetochores, which in turn phosphorylates H2A at T120 and recruits Sgo. In the absence of Mps1 activity AurB recruitment is reduced and delayed but not abolished. Finally, the authors use elegant fusion protein targeting approaches to show that (1) kinetochore recruitment of Mps1 stimulates Bub1 & Sgo1 localization and H2A-T120 phosphorylation and (2) that Mps1-controlled AurB recruitment is important for chromosome alignment. Based on these data and other recently published work, the authors propose a model that suggests a positive feedback between Mps1 and AurB ensures the rapid recruitment of both kinases to kinetochores at mitotic entry in order to set up the mitotic checkpoint and correct erroneous MT/kinetochore attachments.
The basic finding of the paper (Mps1 controls timely AurB kinetochore recruitment) should be interesting for readers in the areas of chromosome biolog , cell division and checkpoint signaling. The manuscript is well written and contains some strong experimental data (e.g. Figure 2 ). However, many experiments in the MS are based on only partially penetrant phenotypes. This likely reflects the biology of the system. Nevertheless, it also necessitates additional considerations for experimental parameters (see below). In the opinion of this reviewer, the MS could be suitable for publication in EMBO Reports after the major points below have addressed. Although analyzing MG132-treated cells in early mitosis is not easy, performing both experiments in the presence of MG132 would provide more convincing data separating the early recruitment versus maintenance role of Mps1 in AurB localization.
-No western blots or other knock-down quantification is provided following the various siRNA treatments (Mps1; BubR1). In the case of BubR1 siRNA in Fig.1A , there is no indication that the checkpoint is indeed inactivated.
-Reversine can inhibit both AurB and reversine -albeit with different efficacy (Santaguida, JCB 2010) . Have the authors tested in their cell model whether 1 micro molar of reversine does have any direct inhibition effect on AurB? Inhibition of AurB also reduces centromere localization under some circumstances. Many findings in the paper could in theory be explained by off-target inhibition of AurB by reversine. It would be helpful if the authors could exclude this possibility.
-Model: The authors do not discuss possible molecular mechanisms underlying the Mps1-controlled AurB recruitment to centromeres. How does Mps1 acitvity promote Sgo1 or Bub1 kinetochore localization? The authors have shown in a previous paper that Mps1 promotes biorientation by modifying Borealin (Jelluma, Cell 2008) . This additional mode of regulation should be included in the model presented in Figure 4C .
Minor points:
Intro -control of Mps1 localization by AurB : artificial retention of AurB at centromeres has been shown to be sufficient for the kinetochore recruitment of Mps1 (Vazquez Novelle, CurrBiol 2010); it would be useful to include this in addition to (Santaguida et al., 2011) and (Saurin et al., 2011) . Referee #1: Most of the interpretations are clear and reasonable, except for a few important issues that the authors must address before publication.
Editor: Address all the concerns of referee 1.
Comments Referee #1: 1) The authors show that the activity of Mps1 is required for the proper localization of CPC (Fig 3) , although this is not surprising since it was already shown that the localizations of Bub1, H2A-pT120, and Sgo1 are dependent on Mps1 (Maciejowski et al., JCB, 2010) . This paper should be cited.
We have cited the paper in the revised manuscript.
We agree with the referee that this is an important point. We now show in two different ways that Mps1 can regulate Sgo1 independently of Bub1-H2Aph:
• As suggested by the referee we expressed a Mis12-Bub1 fusion protein in cells to tether Bub1 to kinetochores independently of Mps1 and found that it could not restore Sgo1 levels at the centromere (Suppl Fig 4A) .
• We also analyzed Sgo1 and Bub1 localisation to kinetochores in G2 cells (see new Fig 3E) . We find that Sgo1 and Bub1 are not present at kinetochores unless Mps1 is localised by Mis12-Mps1 expression. This recruitment of Bub1 and Sgo1 is dependent on Mps1 activity, because it was suppressed by addition of Reversine. Importantly, the localization of Sgo1 occurs even though histone H2A-T120 phosphorylation (the Bub1 -dependent Sgo1 recruitment mark; Kawashima et al, Science, 2010) is absent in these G2 cells (Fig 3E) . This strongly suggests that Mps1 can promote Sgo1 centromere recruitment independently of Bub1-H2A-T120ph.
3) In Fig.4 We understand the referee's concern and planned to perform the suggested experiments. However before embarking on these rather complex experiments we decided to first test if borealin is in fact incorporated into a CB-INCENP-Aurora B complex at the centromere. We found that although WT-INCENP can rescue borealin localisation following INCENP knockdown, CB-INCENP cannot (while it can recover Aurora B localization as shown in Fig 4A) . This data (which is shown below in Fig R1) Because of this, it will be very difficult to provide solid experimental proof that the residual alignment defects are attributed by a lack of Mps1-dependent phosphorylation of borealin. We have therefore changed the text and included the possibility of a CPC-independent role of Mps1 in chromosome alignment, as suggested.
Referee #2: I have one main concern with this paper as it stands: the authors rely on one inhibitor to inhibit each kinase and do not shown any kinase assays for us to judge how efficient these are in their cells. I recommend that the authors repeat their experiments using another inhibitor for Mps1 and for Aurora B (for example the Astra Zeneca compounds). Better still they might consider repeating their experiments in the analogue-sensitive Mps1 cell-line generated by Prasad Jallepalli. I also suspect that live-cell analyses may be more informative given that the authors postulate that there is a limited time window in which Mps1 and Aurora B act on each other, but this is too much to ask here.
Editor: Perform 2-3 key experiments using another Mps1 inhibitor or an analogsensitive Mps1 cell line (not all the experiments, as referee 2 requests).
We repeated a number of key experiments: 1) Aurora B centromere recruitment, 2) Sgo1 centromere recruitment, and 3) chromosome alignment defects) with a second Mps1 inhibitor (Mps1-IN-1, Kwaitkowski et al., Nat Chem Biol, 2010). We found that inhibition of Mps1 by this inhibitor also reduces the centromeric accumulation of Aurora B (Fig 1B) and Sgo1 (Suppl Fig 3B) , and gives rise to chromosome alignment defects that can be greatly improved by expression of CB-INCENP (Suppl Fig 4B) . Furthermore, in the original version of the manuscript we showed that knock-down of Mps1 by siRNA also affects the centromere recruitment of Aurora B (Fig 1A) .
One minor point is that the legend to Fig 2A-C does not mention the numbers of cells and number of independent experiments. We have fixed this in the revised manuscript.
Referee #3: The basic finding of the paper (Mps1 controls timely AurB kinetochore recruitment) should be interesting for readers in the areas of chromosome biology, cell division and checkpoint signaling. The manuscript is well written and contains some strong experimental data (e.g. Figure 2 ). However, many experiments in the MS are based on only partially penetrant phenotypes. This likely reflects the biology of the system. Nevertheless, it also necessitates additional considerations for experimental parameters (see below). In the opinion of this reviewer, the MS could be suitable for publication in EMBO Reports after the major points below have addressed.
Editor: Address the first three major comments and the fourth minor point of referee 3. As the referee rightfully comments, analyzing MG132-treated cells in early mitosis is not easy, because proteasome inhibition affects mitotic entry. For that reason we designed the experiments presented in figure 2: We performed a dynamic assay in which we inhibited Cdk1 activity in mitotic cells, and then reactivated Cdk1 in these cells (by removal of the inhibitor) either in the presence or absence of active Mps1 (fig 2) . In these experiments MG132 was continuously present and we still found a delay in recovery of Aurora B centromere localization when Mps1 was inhibited. This already indicates that MG132 by itself does not have an effect. Nevertheless, we now also performed the mitotic entry assay in the presence of MG132 and found that in the cells that did enter mitosis both Aurora B and Sgo1 levels were reduced when Mps1 was inhibited (shown below in Fig R2) . We feel that this solidifies our conclusion that Mps1 is required for the early recruitment of Aurora B not for maintenance.
2) No western blots or other knock-down quantification is provided following the various siRNA treatments (Mps1; BubR1). In the case of BubR1 siRNA in Fig.1A , there is no indication that the checkpoint is indeed inactivated.
We now show western blots and functional assays to demonstrate that siRNAs knock-down reduces the respective proteins levels and overrides the mitotic checkpoint in nocodazole treated cells (Suppl Fig. 1B, C) .
3) Reversine can inhibit both AurB and reversine -albeit with different efficacy (Santaguida, JCB 2010) . Have the authors tested in their cell model whether 1 micro molar of reversine does have any direct inhibition effect on AurB? Inhibition of AurB also reduces centromere localization under some circumstances. Many findings in the paper could in theory be explained by off-target inhibition of AurB by reversine. It would be helpful if the authors could exclude this possibility.
In the original manuscript we used HeLa cells and UTR cells (U2OS cells stably expressing a Tet-Repressor;pcDNA6/TR) for our analysis, while in recent experiment for this rebuttal we also used U2OS cells. For all these cell lines we tested to what extent the used concentrations of reversine or Mps1-IN-1 affected Aurora B activity in cells using Histone H3 Ser-10 phosphorylation as read out. In Suppl Fig 1A we now show that 1 µM reversine does not affect Aurora B kinase activity in HeLa or UTR cells while it does in U2OS cells. Importantly, in all cell lines 10 µM of Mps1-IN-1 did not affect Aurora B kinase activity. Therefore in the U2OS cell experiment we used a lower concentration of reversine (500 nM) that did not affect Aurora B activity and found that it still perturbed Aurora B (Fig. 1B) and Sgo1 localization (Suppl Fig 3B) . Based on these careful experiments, our initial Mps1 knock-down experiments, and our new data to repeat three key experiments with a second Mps1 inhibitor (Mps-IN-1; see response to reviewer 2), we are confident that the observed phenotypes are due to Mps1 inhibition and not due to non-specific Aurora B inhibition. 4) Model: The authors do not discuss possible molecular mechanisms underlying the Mps1-controlled AurB recruitment to centromeres. How does Mps1 acitvity promote Sgo1 or Bub1 kinetochore localization? The authors have shown in a previous paper that Mps1 promotes biorientation by modifying Borealin (Jelluma, Cell 2008) . This additional mode of regulation should be included in the model presented in Figure 4C .
We have now commented in the text that Mps1 could affect Aurora B activity through direct Borealin phosphorylation. For figure 4C , however, we would like to illustrate the main conclusion of this manuscript: The localisation dependent control network that exists between Mps1 and Aurora B. The localisation of Aurora B to centromeres does not depend on Borealin phosphorylation by Mps1 (Jelluma et al., Cell 2008) and therefore we feel this pathway should not be included in figure 4C .
Minor points: 1) Intro -control of Mps1 localization by AurB : artificial retention of AurB at centromeres has been shown to be sufficient for the kinetochore recruitment of Mps1 (Vazquez Novelle, CurrBiol 2010); it would be useful to include this in addition to (Santaguida et al., 2011) and (Saurin et al., 2011) .
We included the reference in the revised version of the manuscript.
2) Fig.1A : AurB seems to be reduced in both centromere and arm locations in cells (e.g. Mps1 siRNA + rev). Is it possible that Mps1 regulates not centromere targeting but overall chromatin binding of the CPC?
We don't think this very likely, as we clearly see arm localization upon Mps1 inhibition. This is best visible in the images generated by CLSM (no deconvolution) in Fig 2B, and Suppl Fig 3C. 3) An important claim is that the effect of Mps1 is through the Bub1/H2A-T120ph axis, and not the Haspin-H3-T3ph axis. It would be important to provide images used to quantify H3-T3ph in Fig. S2A .
Images of H3-T3ph after Mps1 inhibition are shown in Suppl Fig. 3D. Fig.3 : treating mis12-Mps1 cells with reversine would reinforce the notion that the increase in Bub1 and T120ph is due to Mps1 activity rather than its ectopic localization alone.
4)
To show this, we expressed Mis12-Mps1 and checked if expression of this fusion protein would be sufficient to drive Bub1 and Sgo1 localization in G2 cells (Bub1 kinetochore, and Sgo1 centromere localization is normally not yet seen in this phase of the cell cycle). Indeed, expression of Mis12-Mps1 did induce localisation of Bub1 and Sgo1 to kinetochores in G2 cells. We also show that this depends on Mps1 kinase activity because Bub1 and Sgo1 localization was abolished when the kinase was inhibited by reversine ( Figure 3 Thank you for your patience while we have reviewed your revised manuscript. The three referees now support its publication in EMBO reports and have no further comments. I am therefore writing with an 'accept in principle' decision, which means that I will be happy to accept your manuscript for publication once a few minor issues/corrections have been addressed, as follows.
I have noticed that in figures 1 A-C, 2C, 4B, SF1C and SF4B you have calculated SD from two independent experiments, which is not appropriate (for guidance, please refer to: Cumming et al. JCB 2007) . In the final manuscript, you either need to present the data from one experiment (without error bars), clearly stating in the legend that this is a representative experiment of two conducted or, ideally, increase the number of independent experiments to three to perform statistical analysis. A good intermediate solution is to represent the individual data points from both experiments in graph format, without error bars. This will allow the readers to see the consistency of the results. In addition, I could not find information regarding the number of independent experiments performed or the identity of the error bars in figure 3E ; please ensure this information is included in the figure legend.
After these remaining corrections have been attended to, you will receive an official decision letter from the journal accepting your manuscript for publication in the next available issue of EMBO reports. This letter will also include details of the further steps you need to take for the prompt inclusion of your manuscript in our next available issue. Thank you for your careful inspection of our manuscript. We have taken your suggestions into account and in addition we consulted a statistician from a neighboring institute. Based on your and his advice we have done the following: analyzed/condition, sampled in 4 (1A) respectively 2 (1B) and 3 (1C) independent experiments. We feel this is the best way to compare the different experiments shown in 1A-C, because it shows both consistency and experimental variation. Since the analyzed cells in one experiment represent different data points and not replicates, we feel this is a valid way to show it (Cumming et al. JCB 2007) . Moreover, we also tested this by a 2-way ANOVA interaction test that demonstrated that the differences are due to the various experimental conditions (e.g. DMSO vs Reversine vs si-Mps1 vs si-Luc) and not due to the variation between experiments. (Note that we do not show this test in the manuscript but used it to test if our way of re-representing the data was appropriate). Suppl Figure 1C : We now show one representative experiment out of two (>2000 cells were counted per condition).
Suppl Figure S4B : We now show one representative experiment out of two (60 cells were analyzed cells per condition).
Finally, note that for matters of consistency we have changed Figure 3E and now show the relative centromere levels of Aurora B upon Sgo1 depletion instead of the "absolute" centromere levels. Also, because we show one representative experiment (which I noticed we did not clearly indicate in the legend) we decided to plot the means (+/-SEM, instead of SD) of 11 cells analyzed/condition, similar to the way we represent the data of figure 2C .
We hope that with these final changes our manuscript is acceptable for publication in EMBO Reports. Thank you for so carefully addressing the statistical analysis of the data. I am now very pleased to accept your manuscript for publication in the next available issue of EMBO reports.
Thank you again for your contribution to EMBO reports and congratulations on a successful publication. Please consider us again in the future for your most exciting work.
Yours sincerely, Editor EMBO Reports
